StockData
Danaher Corp logo

Danaher Corp

DHRNYSEIndustrial Instruments For Measurement, Display, and ControlFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 26, 2026Last filing: 10-Q on Jul 21, 2026Score 12/3025% above fair value
$227.97−4.26 (-1.83%)

Close on Nov 2, 2026Market cap $160.26BP/E 40.5Yield –

Danaher Cepheid (GeneXpert Molecular Diagnostics) by Year

Cepheid (GeneXpert Molecular Diagnostics) — FDA 510(k) Clearances

QuarterlyAnnualMonthly

Danaher Cepheid (GeneXpert Molecular Diagnostics): 6 in FY2025, up 50.0% from a year earlier. That is the highest of the 11 years on record here.

Latest, FY2025
6
Period ended Dec 31, 2025
Change on a year earlier
+50.0%
4 in FY2024
History
11 years
Since FY2015
Sources
1
U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE)

Where the FY2025 figure comes from

Source: U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗

Reported in U.S. FDA openFDA Device 510(k) Clearances API.

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedCepheid (GeneXpert Molecular Diagnostics) — FDA 510(k) ClearancesYear on yearSource
FY2025Dec 31, 20256+50.0%U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗
FY2024Dec 31, 20244-20.0%U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗
FY2023Dec 31, 20235+66.7%U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗
FY2022Dec 31, 20223–U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗
FY2021Dec 31, 20210–U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗
FY2020Dec 31, 20200-100.0%U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗
FY2019Dec 31, 20193-40.0%U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗
FY2018Dec 31, 20185+25.0%U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗
FY2017Dec 31, 201740.0%U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗
FY2016Dec 31, 20164+33.3%U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗
FY2015Dec 31, 20153–U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗

Cite this data

StockData. (2026). Danaher Cepheid (GeneXpert Molecular Diagnostics), annual FY2015–FY2025 [Data set]. Compiled from Danaher SEC filings and investor materials. https://stockdatahq.com/stocks/dhr/kpis/ext-fda-510k-cepheid

See every metric in the Danaher KPI table. Data updated Nov 2, 2026.